Acute Respiratory Syndrome Treatment Market Size, Share 2024-2032

Acute Respiratory Syndrome Treatment Market

The ‘Global Acute Respiratory Syndrome Treatment Market Size, Share, Price, Trends, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global acute respiratory syndrome treatment market, assessing the market on the basis of its segments like drug class, route of administration, treatment channel, and major region.

The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

Acute Respiratory Syndrome Treatment Market Price, Share, Size, Growth, Trends, Industry Report, Key Player, Major Segments and Forecast

The key highlights of the report include:

Market Overview (2018-2031)

• Historical Market Size (2023): USD 860.2 million
• Forecast CAGR (2024-2031): 10.1%
• Forecast Market Size (2032): USD 2045 million

Rising prevalence and incidence of acute lung injury, a wide range of acute respiratory distress syndrome (ARDS) risk factors, and a growth in the number of COVID-19 patients with acute respiratory syndrome are the main drivers of the acute respiratory syndrome treatment market. The global market for acute respiratory syndrome treatment also has potential for expansion due to rising healthcare spending and strategic initiatives made by market players. Due to the availability of modern technology equipment for enhanced treatments and surgical operations through public and private channels like hospitals and clinics, the treatment channels are expanding quickly.

Get a Free Sample Report with Table of Contents:

The development of new products by market participants, rising number of patients, and the growing number of hospital admissions with ARDS are also anticipated to increase the market expansion throughout the course of the forecast period. The acute respiratory syndrome treatment market growth is being supported by the rising number of hospitals being built by private businesses. Rise in hospital admissions and critical care unit admissions are bolstering the need for advanced treatment, which, in turn, is propelling the market expansion.

Acute Respiratory Syndrome Treatment Industry Definition and Major Segments

Acute respiratory distress syndrome (ARDS) is caused by fluid build-up in the alveoli of the lungs, which are small, elastic air sacs. Due to the fluid’s capacity to restrict the lungs from breathing in enough air, less oxygen enters the bloodstream. A person is more prone to develop ARDS if they are already severely unwell or have significant injuries. Severe shortness of breath is a main symptom of ARDS and often develops a few hours to a few days after the sickness or injury that caused it. Acute respiratory syndrome treatment focuses on keeping the patient comfortable while the lungs heal and treating underlying causing conditions.

Read Full Report with Table of Contents:

Based on drug class, the market is segmented into:

• Vasoconstrictor
• Bronchodilators
• Steroids
• Antibiotics
• Nitric Oxide
• Sedatives and Paralytics
• Surfactant
• Others

On the basis of route of administration, the market is divided into:

• Oral
• Inhalation
• Parenteral
• Others

Based on treatment channel, the market is bifurcated into:

• Public
• Private

On the basis of region, the market is divided into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Acute Respiratory Syndrome Treatment Market Trends

The key trends driving the global acute respiratory syndrome treatment market expansion are the increasing rates of acute respiratory syndrome-causing trauma, air pollution, and lifestyle-related diseases, as well as rising rates of accidents and lifestyle-related diseases. The global market has the potential to expand due to factors such as ageing populations, rising healthcare costs, and strategic market player initiatives.

Other market trends include the development of new products, more awareness of disease management, and a rise in intensive care units for new-borns, whose disease incidence is higher than that of adults. In the upcoming years, the global acute respiratory syndrome treatment market will also be fuelled by an increase in research into stem cell therapies and new projects for research and development.

Efforts by various governments to lower mortality rate will likely play a significant role in the expansion of the global market for acute respiratory syndrome treatment. Infectious disease prevalence and rising prescriptions for combination therapy medications are risk factors linked to the spread of severe acute respiratory syndrome, increasing the demand for its treatment.

At a regional level, North America accounts for a significant share of the global acute respiratory syndrome treatment market. This can be attributed to the presence of key market participants, an increase in product approvals, a developed healthcare system, and high frequency of acute respiratory distress syndrome.

Key Market Players

The major players in the acute respiratory syndrome treatment market report include:

  • AIkido Pharma Inc.
  • Aceto Corporation
  • Global BioLife Inc Ltd
  • Faron Pharmaceuticals
  • PhaseBio Pharmaceuticals
  • Sage Therapeutics Sage Therapeutics
  • Emergent BioSolutions
  • Kiniksa Pharmaceuticals, Ltd
  • Biomarck Pharmaceuticals, Ltd.
  • Athersys, Inc
  • Direct Biologics

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.

Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.

Media Contact:

Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: [email protected]
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA